Ching-Chuan Kuo - JoVE Visualize

Showing results (91-100 of 98) with videos related to

Pageof 10

Sort By:

You have reached the last page of results.This site can display upto 98 results.

Molecular Cancer Therapeutics|January 24, 2007

D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activationShin-Hun Juang, Chia-Chi Lung, Pi-Chen Hsu, et al.

Journal of Medicinal Chemistry|July 10, 2009

Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approachYu-Shan Wu, Mohane Selvaraj Coumar, Jang-Yang Chang, et al.

Developmental Cell|March 29, 2025

KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubulesYuan-Shao Pao, Kuan-Ju Liao, Ya-Chia Shiau, et al.

Journal of Medicinal Chemistry|December 15, 2015

Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor EfficacyShu-Yu Lin, Teng-Kuang Yeh, Ching-Chuan Kuo, et al.

Oncotarget|November 19, 2016

Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluationYung Chang Hsu, Mohane Selvaraj Coumar, Wen-Chieh Wang, et al.

Bioorganic Chemistry|March 2, 2018

4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacyShu-Yu Lin, Teng-Kuang Yeh, Jen-Shin Song, et al.

European Journal of Medicinal Chemistry|December 20, 2021

Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug designTeng-Kuang Yeh, Jen-Shin Song, Po-Wei Chang, et al.

Journal of Medicinal Chemistry|November 14, 2019

Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid LeukemiaWen-Hsing Lin, Su-Ying Wu, Teng-Kuang Yeh, et al.

Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:

Pageof 10

You have reached the last page of results.This site can display upto 98 results.

Molecular Cancer Therapeutics|January 24, 2007

D-501036, a novel selenophene-based triheterocycle derivative, exhibits potent in vitro and in vivo antitumoral activity which involves DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activationShin-Hun Juang, Chia-Chi Lung, Pi-Chen Hsu, et al.

Journal of Medicinal Chemistry|July 10, 2009

Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approachYu-Shan Wu, Mohane Selvaraj Coumar, Jang-Yang Chang, et al.

Developmental Cell|March 29, 2025

KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubulesYuan-Shao Pao, Kuan-Ju Liao, Ya-Chia Shiau, et al.

Journal of Medicinal Chemistry|December 15, 2015

Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor EfficacyShu-Yu Lin, Teng-Kuang Yeh, Ching-Chuan Kuo, et al.

Oncotarget|November 19, 2016

Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluationYung Chang Hsu, Mohane Selvaraj Coumar, Wen-Chieh Wang, et al.

Bioorganic Chemistry|March 2, 2018

4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacyShu-Yu Lin, Teng-Kuang Yeh, Jen-Shin Song, et al.

European Journal of Medicinal Chemistry|December 20, 2021

Discovery and development of a novel N-(3-bromophenyl)-{[(phenylcarbamoyl)amino]methyl}-N-hydroxythiophene-2-carboximidamide indoleamine 2,3-dioxygenase inhibitor using knowledge-based drug designTeng-Kuang Yeh, Jen-Shin Song, Po-Wei Chang, et al.

Journal of Medicinal Chemistry|November 14, 2019

Identification of a Multitargeted Tyrosine Kinase Inhibitor for the Treatment of Gastrointestinal Stromal Tumors and Acute Myeloid LeukemiaWen-Hsing Lin, Su-Ying Wu, Teng-Kuang Yeh, et al.

Pageof 10